MTOR and non-small cell lung carcinoma: Wnt/β-catenin signaling pathway promoted EMT of NSCLC [33], whereas the phosphatidylinositol 3-kinase/serine/threonine protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) signaling pathway was involved in initiating EMT in OSCC [32].